Nanostics develops better tests En Route magazineForward Momentum2022-02-08T23:37:35+00:00
About Forward Momentum
This author has not yet filled in any details.So far Forward Momentum has created 33 blog entries.
ClarityDX Prostate is one of five top picks for mind-blowing technologies and treatments in 2018
Forward Momentum2022-02-08T23:01:45+00:00Global Edmonton Health reporter Su-Ling Goh highlighted 5 amazing medical technologies and treatments from Edmonton research teams and ClarityDX Prostate was one of them!
Edmonton Journal – New lab brings fledgling health tech companies together in shared space
Forward Momentum2022-01-04T19:16:16+00:00A local startup with plans to market a more accurate prostate cancer screening test is one of the first businesses to set up shop in a new downtown shared lab space for health tech companies.
Intravital imaging tumor screen used to identify novel metastasis-blocking therapeutic targets
Forward Momentum2022-01-04T18:56:47+00:00This is a micro-review of an original research article from the Lewis research group that identified multiple novel metastasis-blocking targets, by using a whole genome screen and intravital imaging approach, that could be used as therapeutic targets to inhibit solid tumour cell motility.
AUTHOR: KONSTANTIN STOLETOV, LIAN WILLETTS, PERRIN H. BEATTY, AND JOHN D. LEWIS
BioAlberta Recognizes Alberta Innovators and Entrepreneurs at 2018 Awards Gala
Forward Momentum2022-01-04T18:49:17+00:00CALGARY, Alberta — At its 2018 awards gala, BioAlberta, the province’s life sciences industry association, recognized two leaders for their innovation and achievements. BioAlberta congratulates Circle Cardiovascular Imaging Inc. for winning its Company of the Year award and Dr. John Lewis for winning its Scientific Achievement and Innovation Award.
FALLING WALLS
Forward Momentum2022-01-04T18:48:55+00:00Dr. John Lewis is the winner of the University of Alberta-TEC Edmonton Falling Walls Venture Competition which earned him entrance to the Falling Walls Finale Competition (the International Conference on Future Breakthroughs in Science and Society) which will be held in Berlin this November. Some travel expenses will be paid for.
A Less Invasive Route to Test For Prostate Cancer
Forward Momentum2022-01-04T19:18:04+00:00Alberta scientists, at Nanostics, have created a blood test that could make a significant impact in the way patients are tested and treated for prostate cancer.
Funding to develop technology that will detect prostate cancer earlier
Forward Momentum2022-02-05T03:17:45+00:00EDMONTON — Alberta Innovates, the Alberta Cancer Foundation and DynaLIFE have joined together to help commercialize Alberta-owned innovations that will detect cancer earlier and improve treatment for Albertans.
NVIDIA – How GPU-Powered Cellular Analysis Could Help Avoid Unnecessary Prostate Cancer Biopsies
Forward Momentum2022-01-04T19:23:19+00:001.3M North American men get biopsies each year checking for prostate cancer, many of them unnecessary. UofA researchers want to change that with a new test that relies on GPU computing.
Startup Nanostics preparing launch of blood-based biomarker test for prostate cancer
Forward Momentum2022-01-04T19:25:26+00:00A new diagnostic will allow men to bypass painful biopsies to test for aggressive prostate cancer.
